Ventilator-associated pneumonia

Current Opinion in Critical Care

Volumn 15, Issue 1, 2009, Pages 30-35

  Valencia, Mauricio ^a   Torres, Antoni ^b  

^a HOSPITAL UNIVERSITARI SAGRAT COR   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Diagnosis; Pneumonia; Prevention; Treatment

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; C REACTIVE PROTEIN; CIPROFLOXACIN; MEROPENEM; PROCALCITONIN;

ACINETOBACTER; ANTIBIOTIC THERAPY; BRONCHOSCOPY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE ESCALATION; DRUG EFFICACY; ENDOTRACHEAL TUBE; FEVER; HOSPITAL INFECTION; HUMAN; HUMIDIFIER; HYPOTHERMIA; INCIDENCE; LEUKOCYTOSIS; LEUKOPENIA; LUNG LAVAGE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONOTHERAPY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS; THORAX RADIOGRAPHY; VENTILATOR ASSOCIATED PNEUMONIA;

HUMANS; INTENSIVE CARE UNITS; PNEUMONIA, VENTILATOR-ASSOCIATED;

EID: 61449100626     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3283220e78     Document Type: Review

References (39)

1. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274:639-644.
2. Heyland DK, Cook DJ, Griffith L, et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999; 159:1249-1256.
3. Girou E, Stephan F, Novara A, et al. Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am J Respir Crit Care Med 1998; 157:1151-1158.
4. Fàbregas N, Ewig S, Torres A, et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate postmortem lung biopsies. Thorax 1999; 54:867-873.
5. Heyland D, Ewig S, Torres A. Pro/con clinical debate: the use of a protected specimen brush in the diagnosis of ventilator associated pneumonia. Crit Care 2002; 6:117-120.
6. Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 2006; 355:2619-2630.
7. Jackson SR, Ernst NE, Mueller EW, Butler KL. Utility of bilateral bronchoalveolar lavage for the diagnosis of ventilator-associated pneumonia in critically ill surgical patients. Am J Surg 2008; 195:159-163.
8. Mentec H, May-Michelangeli L, Rabbat A, et al. Blind and bronchoscopic sampling methods in suspected ventilator-associated pneumonia. A multi-centre prospective study. Intensive Care Med 2004; 30:1319-1326.
9. Leo A, Galindo-Galindo J, Folch E, et al. Comparison of bronchoscopic bronchoalveolar lavage vs blind lavage with a modified nasogastric tube in the etiologic diagnosis of ventilator-associated pneumonia. Med Intensiva 2008; 32:115-120.
10. Flanagan PG, Findlay GP, Magee JT, et al. The diagnosis of ventilator-associated pneumonia using nonbronchoscopic, nondirected lung lavages. Intensive Care Med 2000; 26:20-30.
11. Linssen CF, Jacobs JA, Schouten JS, et al. Influence of antibiotic therapy on the cytological diagnosis of ventilator-associated pneumonia. Intensive Care Med 2008; 34:865-872.
12. Timsit JF, Cheval C, Gachot B, et al. Usefulness of a strategy based on bronchoscopy with direct examination of bronchoalveolar lavage fluid in the initial antibiotic therapy of suspected ventilator-associated pneumonia. Intensive Care Med 2001; 27:640-647.
13. Lorente L, Lecuona M, Jiménez A, et al. Ventilator-associated pneumonia using a heated humidifier or a heat and moisture exchanger: a randomized controlled trial. Crit Care 2006; 10:R116.
14. Siempos II, Vardakas KZ, Kopfendes P, Falagas ME. Impact of passive humidification on clinical outcomes of mechanically ventilated patients: a meta-analysis of randomized controlled trials. Crit Care Med 2007; 35:2843-2851.
15. Siempos II, Vardakas KZ, Falagas ME. Closed tracheal suction systems for prevention of ventilator-associated pneumonia. Br J Anaesth 2008; 100:299-306.
16. Subirana M, Solá I, Benito S. Closed tracheal suction systems versus open tracheal suction systems for mechanically ventilated adult patients. Cochrane Database Syst Rev 2007:CD004581.
17. Lindgren S. Regional lung derecruitment after endotracheal suction during volume- or pressure-controlled ventilation: a study using electric impedance tomography. Intensive Care Med 2007; 33:172-180.
18. Vallés J, Artigas A, Rello J, Bonsoms N, et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med 1995; 122:179-186.
19. Dezfulian C, Shojania K, Collard HR, et al. Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis. Am J Med 2005; 118:11-18.
20. Dullenkopf A, Gerber A, Weiss M. Fluid leakage past tracheal tube cuffs: evaluation of the new Microcuff endotracheal tube. Intensive Care Med 2003; 29:1849-1853.
21. Poelaert J, Depuydt P, De Wolf A, et al. Polyurethane cuffed endotracheal tubes to prevent early postoperative pneumonia after cardiac surgery: a pilot study. J Thorac Cardiovasc Surg 2008; 135:771-776.
22. Lorente L, Lecuona M, Jiménez A, et al. Influence of an endotracheal tube with polyurethane cuff and subglottic secretion drainage on pneumonia. Am J Respir Crit Care Med 2007; 176:1079-1083.
23. Smulders K, van der Hoeven H, Weers-Pothoff I, Vandenbroucke-Grauls C. A randomized clinical trial of intermittent subglottic secretion drainage in patients receiving mechanical ventilation. Chest 2002; 121:858-862.
24. Dragoumanis CK, Vretzakis GI, Papaioannou VE, et al. Investigating the failure to aspirate subglottic secretions with the Evac endotracheal tube. Anesth Analg 2007; 105:1083-1085.
25. Inglis TJ, Lim TM, Ng ML, et al. Structural features of tracheal tube biofilm formed during prolonged mechanical ventilation. Chest 1995; 108:1049-1052.
26. Kollef MH, Afessa B, Anzueto A, NASCENT Investigation Group. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2008; 300:805-813.
27. Raad I, Darouiche R, Hachem R, et al. The broad-spectrum activity and efficacy of catheters coated with minocycline and rifampin. J Infect Dis 1996; 173:418-424.
28. Iregui M, Ward S, Sherman G, et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002; 122:262-268.
29. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Med 1996; 22:387-394.
30. Kuti EL, Patel AA, Coleman Cl. Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis. Crit Care 2008; 23:91-100.
31. Parker CM, Kutsogiannis J, Muscedere J, et al. Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes. J Crit Care 2008; 23: 18-26.
32. Sanders KM, Adhikari NK, Friedrich JO, et al. Previous cultures are not clinically useful for guiding empiric antibiotics in suspected ventilator-associated pneumonia: secondary analysis from a randomized trial. J Crit Care 2008; 23:58-63.
33. Depuydt P, Benoit D, Vogelaers D, et al. Systematic surveillance cultures as a tool to predict involvement of multidrug antibiotic resistant bacteria in ventilator-associated pneumonia. Intensive Care Med 2008; 34:675-682.
34. Joffe AR, Muscedere J, Marshall JC, et al. The safety of targeted antibiotic therapy for ventilator-associated pneumonia: a multicenter observational study. J Crit Care 2008; 23:82-90.
35. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003; 290:2588-2598.
36. Giantsou E, Liratzopoulos N, Efraimidou E, et al. De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate. Intensive Care Med 2007; 33:1533-1540.
37. Safdar N, Handelsman J, Maki DG. Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis 2004; 4:519-527.
38. Garnacho-Montero J, Sa-Borges M, Sole-Violan J, et al. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy. Crit Care Med 2007; 35:1888-1895.
39. Heyland DK, Dodek P, Muscedere J, et al. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Crit Care Med 2008; 36:737-744.